BACKGROUND: Donepezil, rivastigmine and galantamine are popular cholinesterase inhibitors used to manage the symptoms of Alzheimer disease and other dementias; regulatory agencies in several countries ...

The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using donepezil, galantamine, rivastigmine and memantine in the NHS in ...

Please provide your email address to receive an email when new articles are posted on . Older patients prescribed donepezil had a higher risk for hospital admission for rhabdomyolysis than patients ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

The Alzheimer's drug donepezil (multiple brands) is associated with a twofold higher risk for hospital admission for rhabdomyolysis, a rare but potentially life-threatening condition in which muscle ...

For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

A class of drugs commonly used to treat Alzheimer’s disease and other dementias in nursing home residents has been found to slow cognitive decline over a five-year period in patients diagnosed with ...

“This study suggests that there is no protective (or harmful) association of memantine [a second-line drug for dementia] or donepezil [a first-line drug] with the risk of developing age-related ...

We lack a randomized, controlled comparison of the cholinesterase inhibitors. However, if one agent were dramatically more effective or substantially more toxic, the differences would be obvious in ...